How explicitly must a complaint sounding in antitrust allege causation? At oral argument last week, the Court of Appeals for the Second Circuit evaluated the sufficiency of the plaintiffs’ allegations that certain Takeda...more
9/23/2016
/ Actos ,
Antitrust Violations ,
Appeals ,
Causation ,
Dismissals ,
False Evidence ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Patents ,
Pharmaceutical Industry ,
Pleading Standards ,
Product Exclusivity ,
Takeda Pharmaceuticals ,
Twombly/Iqbal Pleading Standard